You are Trying to View a Free Article

Daily News You Can't Find Anywhere Else

North Carolina's Pharma/Biotech Capital Construction Project Activity Remains Strong, an Industrial Info Market Brief

default

Industry Segment: Market Brief | Word Count: 82 Words
Attachment: Map

North Carolina continues to see a surge of Pharmaceutical/Biotech construction activity. Major firms such as Merck, Eli Lilly, Pfizer and Grifols are either planting or expanding their manufacturing roots in the state. North Carolina's attraction can be attributed to its skilled workforce, state/local incentives, and proximity to other pharma/biotech firms.

Subscribe Now! All Fields Required...

Standard Membership - Free